Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699 · see citing works

Diagnosing the decline in pharmaceutical R&D efficiency

Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3681 · Cited by 1,981 · see citing works

Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes

McGuigan, A. J., Kelly, P. J., Turkington, R. C., Jones, C. A., Coleman, H. G., & McCain, R. S. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i43.4846 · Cited by 1,933 · see citing works

Challenges in diagnosis of pancreatic cancer

Zhang, L., Sanagapalli, S., & Stoita, A. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i19.2047 · Cited by 600 · see citing works

Activation of sphingosine kinase 1 by ERK1/2‐mediated phosphorylation

Pitson, S. M., Moretti, P. A. B., Zebol, J. R., Lynn, H. E., Xia, P., Vadas, M. A., & Wattenberg, B. W. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg540 · Cited by 543 · see citing works

Sphingosine kinase, sphingosine-1-phosphate, and apoptosis

Maceyka, M. W., Payne, S. G., Milstien, S., & Spiegel, S. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00341-4 · Cited by 543 · see citing works

Early detection of pancreatic cancer

Pereira, S. P., Oldfield, L., Ney, A., Hart, P. A., Keane, M. G., Pandol, S. J., Li, D., Greenhalf, W., Jeon, C. Y., Koay, E. J., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30416-9 · Cited by 482 · see citing works

Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases

Hait, N. C., Oskeritzian, C. A., Paugh, S. W., Milstien, S., & Spiegel, S. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.08.007 · Cited by 478 · see citing works

International Union of Pharmacology. XXXIV. Lysophospholipid Receptor Nomenclature

Chun, J. J. M., Goetzl, E. J., Hla, T., Igarashi, Y., Lynch, K. R., Moolenaar, W., Pyne, S., & Tigyi, G. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.265 · Cited by 464 · see citing works

Interleukin-17–induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer

Zhang, Y., Chandra, V., Riquelme, E. M., Dutta, P., Quesada, P. R., Rakoski, A. I., Zoltan, M. A., Arora, N., Baydogan, S., Horne, W. T., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190354 · Cited by 447 · see citing works

Drug repurposing from the perspective of pharmaceutical companies

Cha, Y., Erez, T., Reynolds, I. J., Kumar, D., Ross, J., Koytiger, G., Kusko, R. L., Zeskind, B. J., Risso, S., Kagan, E., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13798 · Cited by 434 · see citing works

STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors

Lee, H., Deng, J., Kujawski, M., Yang, C., Liu, Y., Herrmann, A., Kortylewski, M., Horne, D., Somlo, G., Forman, S., et al. (2010) · Nature Medicine · doi:10.1038/nm.2250 · Cited by 395 · see citing works

Pharmacology and Antitumor Activity of ABC294640, a Selective Inhibitor of Sphingosine Kinase-2

French, K. J., Zhuang, Y., Maines, L. W., Gao, P., Wang, W., Beljanski, V., Upson, J. J., Green, C. L., Keller, S. N., & Smith, C. D. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.163444 · Cited by 319 · see citing works

The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance

Park, S., Lee, C.-J., Choi, J.-H., Kim, J., Kim, J., Kim, J. Y., & Nam, J. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1405-7 · Cited by 295 · see citing works

The roles of nuclear focal adhesion kinase (FAK) on Cancer: a focused review

Zhou, J., Yi, Q., & Tang, L. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1265-1 · Cited by 292 · see citing works

Regulation and functional roles of sphingosine kinases

Alemany, R., van Koppen, C. J., Danneberg, K., ter Braak, M., & zu Heringdorf, D. M. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0132-3 · Cited by 232 · see citing works

Pancreatic cancer treatment: better, but a long way to go

Torphy, R. J., Fujiwara, Y., & Schulick, R. D. (2020) · Surgery Today · doi:10.1007/s00595-020-02028-0 · Cited by 199 · see citing works

A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors

Britten, C. D., Garrett-Mayer, E. S., Chin, S. H., Shirai, K., Öğretmen, B., Bentz, T. A., Brisendine, A., Anderton, K., Cusack, S., Maines, L. W., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2363 · Cited by 168 · see citing works

Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB signaling

Li, J., Wu, H., Li, W., Yin, L., Guo, S., Xu, X. M., Ouyang, Y., Zhao, Z., Liu, S., Tian, Y., et al. (2016) · Oncogene · doi:10.1038/onc.2016.90 · Cited by 167 · see citing works

Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature

Guerini, A. E., Triggiani, L., Maddalo, M., Bonù, M. L., Frassine, F., Baiguini, A., Alghisi, A., Tomasini, D., Borghetti, P., Pasinetti, N., et al. (2019) · Cancers · doi:10.3390/cancers11091284 · Cited by 146 · see citing works

Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways

Dogra, N., Kumar, A., & Mukhopadhyay, T. K. (2018) · Scientific Reports · doi:10.1038/s41598-018-30158-6 · Cited by 114 · see citing works

Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts

Beljanski, V., Lewis, C. S., & Smith, C. D. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.5.14677 · Cited by 110 · see citing works

Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myeloma

Venkata, J. K., An, N., Stuart, R. K., Costa, L. J., Cai, H., Coker, W. J., Song, J. H., Gibbs, K., Matson, T., Garrett-Mayer, E. S., et al. (2014) · Blood · doi:10.1182/blood-2014-03-559385 · Cited by 101 · see citing works

Pancreatic cancer: An update on diagnosis and management

Loveday, B. P. T., Lipton, L. R., & Thomson, B. N. J. (2019) · Australian Journal of General Practice · doi:10.31128/ajgp-06-19-4957 · Cited by 94 · see citing works

Brain Penetration and Efficacy of Different Mebendazole Polymorphs in a Mouse Brain Tumor Model

Bai, R.-Y., Staedtke, V., Wanjiku, T. M., Rudek, M. A., Joshi, A. D., Gallia, G. L., & Riggins, G. J. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2681 · Cited by 82 · see citing works

Curcumin Suppresses Phthalate-Induced Metastasis and the Proportion of Cancer Stem Cell (CSC)-like Cells via the Inhibition of AhR/ERK/SK1 Signaling in Hepatocellular Carcinoma

Tsai, C.-F., Hsieh, T.-H., Lee, J.-N., Hsu, C., Wang, Y., Kuo, K.-K., Wu, H., Chiu, C., Tsai, E., & Kuo, P.-L. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b04415 · Cited by 74 · see citing works

Mebendazole Potentiates Radiation Therapy in Triple-Negative Breast Cancer

Zhang, L., Dratver, M. B., Yazal, T., Dong, K., Nguyen, A., Yu, G., Dao, A., Dratver, M. B., Duhachek-Muggy, S., Bhat, K., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.08.046 · Cited by 71 · see citing works

Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy

Huwiler, A., & Zangemeister‐Wittke, U. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.04.010 · Cited by 65 · see citing works

Combined anticancer effects of sphingosine kinase inhibitors and sorafenib

Beljanski, V., Knaak, C., Zhuang, Y., & Smith, C. D. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9452-0 · Cited by 65 · see citing works

Surgical treatment of pancreatic cancer

Masiak, W., Rawicz‐Pruszyński, K., Skórzewska, M., & Polkowski, W. P. (2018) · Polish Journal of Surgery · doi:10.5604/01.3001.0011.7493 · Cited by 60 · see citing works

Altering the Sphingosine-1-Phosphate/Ceramide Balance: A Promising Approach for Tumor Therapy

Huwiler, A., & Pfeilschifter, J. M. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206779010422 · Cited by 60 · see citing works

The anthelmintic drug mebendazole inhibits growth, migration and invasion in gastric cancer cell model

Pinto, L. C., Soares, B. M., Pinheiro, J. D. J. V., Riggins, G. J., de Assumpção, P. P., Burbano, R. M. R., & Montenegro, R. C. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.08.007 · Cited by 59 · see citing works

A novel role of sphingosine kinase‐1 in the invasion and angiogenesis of VHL mutant clear cell renal cell carcinoma

Salama, M., Carroll, B. L., Adada, M. M., Pulkoski‐Gross, M. J., Hannun, Y. A., & Obeid, L. M. (2015) · The FASEB Journal · doi:10.1096/fj.15-270413 · Cited by 56 · see citing works

The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic Cancer

Florio, R., Veschi, S., di Giacomo, V., Pagotto, S., Carradori, S., Verginelli, F., Cirilli, R., Casulli, A., Grassadonia, A., Tinari, N., et al. (2019) · Cancers · doi:10.3390/cancers11122042 · Cited by 54 · see citing works

Potential and mechanism of mebendazole for treatment and maintenance of ovarian cancer

Elayapillai, S., Ramraj, S., Benbrook, D. M., Bieniasz, M., Wang, L., Pathuri, G., Isingizwe, Z. R., Kennedy, A. L., Zhao, Y. D., Lightfoot, S., et al. (2021) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.10.010 · Cited by 50 · see citing works

Inhibition of JAK2/STAT3 signaling pathway by panaxadiol limits the progression of pancreatic cancer

Fan, X., Fu, H., Xie, N., Guo, H., Fu, T., & Shan, Y. (2021) · Aging · doi:10.18632/aging.203575 · Cited by 42 · see citing works

Screening of Benzimidazole-Based Anthelmintics and Their Enantiomers as Repurposed Drug Candidates in Cancer Therapy

Florio, R., Carradori, S., Veschi, S., Brocco, D., Genni, T. D., Cirilli, R., Casulli, A., Cama, A., & Lellis, L. D. (2021) · Pharmaceuticals · doi:10.3390/ph14040372 · Cited by 38 · see citing works

Different Roles of Sphingosine Kinase 1 and 2 in Pancreatic Cancer Progression

Yuza, K., Nakajima, M., Nagahashi, M., Tsuchida, J., Hirose, Y., Miura, K., Tajima, Y., Abe, M., Sakimura, K., Takabe, K., et al. (2018) · Journal of Surgical Research · doi:10.1016/j.jss.2018.06.019 · Cited by 35 · see citing works

Mebendazole inhibits tumor growth and prevents lung metastasis in models of advanced thyroid cancer

Williamson, T., Mendes, T. B., Joe, N., Cerutti, J. M., & Riggins, G. J. (2019) · Endocrine Related Cancer · doi:10.1530/erc-19-0341 · Cited by 35 · see citing works

Mebendazole disrupts stromal desmoplasia and tumorigenesis in two models of pancreatic cancer

Williamson, T., de Abreu, M. C., Trembath, D. G., Brayton, C. F., Kang, B., Mendes, T. B., de Assumpção, P. P., Cerutti, J. M., & Riggins, G. J. (2021) · Oncotarget · doi:10.18632/oncotarget.28014 · Cited by 35 · see citing works

Impairment of the Ubiquitin-Proteasome Pathway by Methyl N-(6-Phenylsulfanyl-1H-benzimidazol-2-yl)carbamate Leads to a Potent Cytotoxic Effect in Tumor Cells

Dogra, N., & Mukhopadhyay, T. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.324228 · Cited by 34 · see citing works

Flubendazole and mebendazole impair migration and epithelial to mesenchymal transition in oral cell lines

Kralova, V., Hanušová, V., Caltová, K., Špaček, P., Hochmalová, M., Skálová, L., & Rudolf, E. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.07.026 · Cited by 30 · see citing works

Sphk1 promotes ulcerative colitis via activating JAK2/STAT3 signaling pathway

Liu, J., & Jiang, B. (2019) · Human Cell · doi:10.1007/s13577-019-00283-z · Cited by 29 · see citing works

Sphingosine kinase 1 contributes to doxorubicin resistance and glycolysis in osteosarcoma

Ren, X., & Su, C. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11295 · Cited by 28 · see citing works

Antiparasitic mebendazole (MBZ) effectively overcomes cisplatin resistance in human ovarian cancer cells by inhibiting multiple cancer-associated signaling pathways

Huang, L., Zhao, L., Zhang, J., He, F., Wang, H., Liu, Q. H., Shi, D., Ni, N., Wagstaff, W., Chen, C., et al. (2021) · Aging · doi:10.18632/aging.203232 · Cited by 28 · see citing works

Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment

Roy-Luzarraga, M., Reynolds, L. E., de Luxán‐Delgado, B., Maiques, Ó., Wisniewski, L., Newport, E., Rajeeve, V., Drake, R. J. G., Gómez-Escudero, J., Richards, F. M., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-20-3807 · Cited by 27 · see citing works

High JAK2 Protein Expression Predicts a Poor Prognosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma

Yang, S. T., Tang, M., Chen, W., Wang, Z., & Wang, S.-L. (2020) · Disease Markers · doi:10.1155/2020/7656031 · Cited by 25 · see citing works

Drug Repurposing in the Development of Anticancer Agents

Ölgen, S., & Kotra, L. P. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867325666180713155702 · Cited by 24 · see citing works

PDAC as an immune evasive disease: can 3D model systems aid to tackle this clinical problem?

Narayanan, S., Vicent, S., & Ponz-Sarvisé, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.787249 · Cited by 24 · see citing works

The Effect of Flubendazole on Adhesion and Migration in SW480 and SW620 Colon Cancer Cells

Hanušová, V., Skálová, L., Králová, V., & Matoušková, P. (2017) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520618666171213141911 · Cited by 24 · see citing works

Chemotherapy, host response and molecular dynamics in periampullary cancer: the CHAMP study

Hau, S. O., Petersson, A., Nodin, B., Karnevi, E., Boman, K., Williamsson, C., Eberhard, J., Leandersson, K., Gisselsson, D., Heby, M., et al. (2020) · BMC Cancer · doi:10.1186/s12885-020-06807-3 · Cited by 21 · see citing works

Pancreatic ductal adenocarcinoma: Emerging therapeutic strategies

Osei‐Bordom, D., Serifis, N., Brown, Z. J., Hewitt, D. B., Lawal, G., Sachdeva, G. S., Cloonan, D. J., & Pawlik, T. M. (2022) · Surgical Oncology · doi:10.1016/j.suronc.2022.101803 · Cited by 17 · see citing works

Development of SKI-349, a dual-targeted inhibitor of sphingosine kinase and microtubule polymerization

Hengst, J. A., Hegde, S., Paulson, R. F., & Yun, J. K. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127453 · Cited by 16 · see citing works

[Role of SPHK1 regulates multi-drug resistance of small cell lung cancer and its clinical significance].

Yang, L., Hu, H., Deng, Y., & Bai, Y. (2014) · Europe PMC (PubMed Central) · doi:10.3779/j.issn.1009-3419.2014.11.01 · Cited by 8 · see citing works

Ecoevolutionary biology of pancreatic ductal adenocarcinoma

Arul, G. L. R., Toruner, M. D., Gatenby, R. A., & Carr, R. M. (2022) · Pancreatology · doi:10.1016/j.pan.2022.06.005 · Cited by 7 · see citing works

Synthesis and Biological Evaluation of BODIPY-PF-543

Shrestha, J., Hwang, G. T., Lee, T., Kim, S. W., Oh, Y. S., Kwon, Y., Hong, S. W., Kim, S., Moon, H. S., Baek, D. J., et al. (2019) · Molecules · doi:10.3390/molecules24234408 · Cited by 7 · see citing works

SK1 Inhibitor RB005 Induces Apoptosis in Colorectal Cancer Cells through SK1 Inhibition Dependent and Independent Pathway

Shrestha, J., Shamshiddinova, M., Lee, Y.-M., Oh, Y. S., Baek, D. J., & Park, E.-Y. (2021) · Current Molecular Pharmacology · doi:10.2174/1874467214666210811151324 · Cited by 7 · see citing works

Human monoclonal antibody SK1-mediated cytotoxicity against colon cancer cells

Chang, H. R., Chavoshan, B., & Park, H. (1993) · Diseases of the Colon & Rectum · doi:10.1007/bf02052265 · Cited by 7 · see citing works

[Sphingosine kinase 1 and tumor].

Zhang, C., He, H., & Shao, R. (2013) · PubMed · Cited by 4 · see citing works

[Sphingosine kinase 1 enhances the proliferation and invasion of human colon cancer LoVo cells through up-regulating FAK pathway and the expression of ICAM-1 and VCAM-1].

Liu, S., Su, Y.-J., Huang, J., Qin, M., & Tang, G. (2013) · PubMed · doi:10.3760/cma.j.issn.0253-3766.2013.05.003 · Cited by 3 · see citing works

Drug repurposing for cancer therapy

Xia, Y., Sun, M., Huang, H., & Jin, W.-L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01808-1 · Cited by 443 · see citing works

Transcriptome and Lipidomic Analysis Suggests Lipid Metabolism Reprogramming and Upregulating SPHK1 Promotes Stemness in Pancreatic Ductal Adenocarcinoma Stem-like Cells

Xu, J., Lina, Z., Du, X., Qi, Z., Chen, S., Zhang, J., Cao, X., & Xia, J. (2023) · Metabolites · doi:10.3390/metabo13111132 · Cited by 15 · see citing works

Targeting sphingosine 1-phosphate and sphingosine kinases in pancreatic cancer: mechanisms and therapeutic potential

Limbu, K. R., Chhetri, R. B., Kim, S.-B., Shrestha, J., Oh, Y. S., Baek, D. J., & Park, E. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03535-7 · Cited by 13 · see citing works

Comparative Studies of Benzimidazoles Synthetic Routes and its Biological Activity

Al-Mahadeen, M. M., & Jaber, A. M. (2024) · Mini-Reviews in Organic Chemistry · doi:10.2174/0118756298334834240828041219 · Cited by 8 · see citing works

Lycorine hydrochloride Suppresses the Proliferation and Invasion of Esophageal Cancer by Targeting TRIM22 and Inhibiting the JAK2/STAT3 and Erk Pathways

Liu, J., Qiu, L., Chen, J., & Zeng, T. (2025) · Cancers · doi:10.3390/cancers17050718 · Cited by 8 · see citing works

Role of Sphingosine-1-Phosphate Signaling Pathway in Pancreatic Diseases

Fu, F., Li, W., Zheng, X., Wu, Y., Du, D., & Han, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111474 · Cited by 7 · see citing works

Mebendazole Exerts Anticancer Activity in Ovarian Cancer Cell Lines via Novel Girdin-Mediated AKT/IKKα/β/NF-κB Signaling Axis

Gupta, R. K., Roy, D., Ghosh, A., Begum, Y., Ghosh, D., & Swarnakar, S. (2025) · Cells · doi:10.3390/cells14020113 · Cited by 7 · see citing works

The m6A reader IGF2BP1 contributes to the activation of hepatic stellate cells through facilitating TUBB4B mRNA stabilization

Li, Y., Chen, L., Li, S., Song, H., Chen, Y., & Wang, S. (2024) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16765 · Cited by 4 · see citing works

Sphingosine Kinase 2 Controls the Aggressive Phenotype of Oral Squamous Cell Carcinoma by Regulating miR-205 and miR-296 through p53

Milan, T. M., SILVA, G. H. D. O., Sousa, L. O., & Leopoldino, A. M. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.09.009 · Cited by 2 · see citing works

Beta-blokerlerin yeniden konumlandırılması: Meme kanseri uygulamaları

ÇİTLER, G. N., & İşeri, Ö. D. (2023) · Frontiers in Life Sciences and Related Technologies · doi:10.51753/flsrt.1152416

Reprogramming tumor immune microenvironment by milbemycin oxime results in pancreatic tumor growth suppression and enhanced anti-PD-1 efficacy

Gaikwad, S. R., & Srivastava, S. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.07.029

Antiparasitic agents in oncology: Innovative mechanisms, emerging evidence and clinical potential in cancer treatment

Al‐Zoubi, R. M., Farhan, A., Hanbali, B., Al-Zoubi, S. R., Khan, A., Shkoor, M., Bani‐Yaseen, A. D., Zoubi, M. S. A., & Agouni, A. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.118987

Sphingosine-1-Phosphate in Pancreatic Ductal Adenocarcinoma

Cardenas, A. (2013) · UA Campus Repository (The University of Arizona)

Inhibition of Sphingosine-1-Phosphate signaling in pancreatic ductal adenocarcinoma leads to downregulation of growth and invasionPreprint

Rheinheimer, B. A., Cardenas, A., Camacho, L., Ong, E., Jie, T., & Heimark, R. L. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.29.318964 · Cited by 1 · see citing works

The effect of mebendazole on proliferation, migration and adhesion of oral cancer cells in vitro

Stupková, E. (2016) · Digital Repository (National Repository of Grey Literature)

PAK1 mediates pancreatic cancer cell migration and resistance to MET inhibition

Zhou, W., Jubb, A. M., Lyle, K. S., Xiao, Q., Ong, C. C., Desai, R. M., Fu, L. L., Gnad, F., Song, Q., Haverty, P. M., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4412 · Cited by 53 · see citing works

Mebendazole disrupts stromal desmoplasia and tumorigenesis in two models of pancreatic cancer

Williamson, T., de Abreu, M. C., Trembath, D. G., Brayton, C. F., Kang, B., Mendes, T. B., de Assumpção, P. P., Cerutti, J. M., & Riggins, G. J. (2021) · Oncotarget · doi:10.18632/oncotarget.28014 · Cited by 35 · see citing works